<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group>
<journal-title>PLoS Pathogens</journal-title></journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-14-01592</article-id>
<article-id pub-id-type="doi">10.1371/journal.ppat.1004410</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Immune receptors</subject><subj-group><subject>Pattern recognition receptors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Infectious disease immunology</subject></subj-group></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Bacteriology</subject><subj-group><subject>Gram negative bacteria</subject></subj-group></subj-group><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Reactive Oxygen Species Regulate Caspase-11 Expression and Activation of the Non-canonical NLRP3 Inflammasome during Enteric Pathogen Infection</article-title>
<alt-title alt-title-type="running-head">ROS Regulates Casp-11 Pathway</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Lupfer</surname><given-names>Christopher R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Anand</surname><given-names>Paras K.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Zhiping</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Stokes</surname><given-names>Kate L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vogel</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lamkanfi</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kanneganti</surname><given-names>Thirumala-Devi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Veterinary Pathology Department, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Medical Protein Research, Vlaams Instituut voor Biotechnologie, Ghent, Belgium</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Biochemistry, Ghent University, Ghent, Belgium</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Monack</surname><given-names>Denise M.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Stanford University School of Medicine, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">Thirumala-Devi.Kanneganti@StJude.org</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: CRL PKA ZL TDK. Performed the experiments: CRL PKA ZL KLS PV. Analyzed the data: CRL PKA ZL PV ML TDK. Contributed reagents/materials/analysis tools: TDK. Contributed to the writing of the manuscript: CRL PKA ML TDK.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>9</month><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>25</day><month>9</month><year>2014</year></pub-date>
<volume>10</volume>
<issue>9</issue>
<elocation-id>e1004410</elocation-id>
<history>
<date date-type="received"><day>4</day><month>7</month><year>2014</year></date>
<date date-type="accepted"><day>19</day><month>8</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Lupfer et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Enteropathogenic and enterohemorrhagic bacterial infections in humans are a severe cause of morbidity and mortality. Although NOD-like receptors (NLRs) NOD2 and NLRP3 have important roles in the generation of protective immune responses to enteric pathogens, whether there is crosstalk among NLRs to regulate immune signaling is not known. Here, we show that mice and macrophages deficient in NOD2, or the downstream adaptor RIP2, have enhanced NLRP3- and caspases-11-dependent non-canonical inflammasome activation in a mouse model of enteropathogenic <italic>Citrobacter rodentium</italic> infection. Mechanistically, NOD2 and RIP2 regulate reactive oxygen species (ROS) production. Increased ROS in <italic>Rip2</italic>-deficient macrophages subsequently enhances c-Jun N-terminal kinase (JNK) signaling resulting in increased caspase-11 expression and activation, and more non-canonical NLRP3-dependant inflammasome activation. Intriguingly, this leads to protection of the colon epithelium for up to 10 days in <italic>Rip2</italic>-deficient mice infected with <italic>C. rodentium</italic>. Our findings designate NOD2 and RIP2 as key regulators of cellular ROS homeostasis and demonstrate for the first time that ROS regulates caspase-11 expression and non-canonical NLRP3 inflammasome activation through the JNK pathway.</p>
</abstract>
<abstract abstract-type="summary"><title>Author Summary</title>
<p>Caspase-11 is required for NLRP3 inflammasome activation and cell death in response to certain gram-negative bacterial infections like <italic>Citrobacter rodentium</italic>. However, how <italic>C. rodentium</italic> drives caspase-11 expression and activation is not well understood. Here, we demonstrate that the NOD2-RIP2 pathway regulates reactive oxygen species production and c-Jun N-terminal kinase signaling to control caspase-11 expression and subsequent activation of caspase-11 and the NLRP3 inflammasome during <italic>C. rodentium</italic> infection. In the absence of NOD2-RIP2 signaling, increased inflammasome activation results in lower bacteria numbers in the colon and less tissue damage during the early stages of infection.</p>
</abstract>
<funding-group><funding-statement>This research was funded by grants to TDK from the National Institutes of Health (<ext-link ext-link-type="uri" xlink:href="http://www.nih.gov" xlink:type="simple">www.nih.gov</ext-link>) through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR056296), the National Institute of Allergy and Infectious Disease (AI101935), and the National Cancer Institute (CA163507). This study was also funded by the American Lebanese Syrian Associated Charities (<ext-link ext-link-type="uri" xlink:href="http://www.stjude.org" xlink:type="simple">www.stjude.org</ext-link>) to TDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="14"/></counts><custom-meta-group><custom-meta id="data-availability" xlink:type="simple"><meta-name>Data Availability</meta-name><meta-value>The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Enteropathogenic and enterohemorrhagic <italic>Escherichia coli</italic> (EPEC and EHEC) infections in humans are a major source of morbidity and mortality, especially in developing countries <xref ref-type="bibr" rid="ppat.1004410-Kaper1">[1]</xref>. To study these infections, <italic>Citrobacter rodentium</italic> is used as an enteric bacterial pathogen of mice that triggers similar inflammatory responses to those observed in humans infected with EPEC and EHEC <xref ref-type="bibr" rid="ppat.1004410-Borenshtein1">[2]</xref>. As with EPEC and EHEC in humans, <italic>C. rodentium</italic> infection in the mouse results in bacterial attachment and effacing lesion formation in the lumen of the colon <xref ref-type="bibr" rid="ppat.1004410-Mundy1">[3]</xref>. Clearance of <italic>C. rodentium</italic> from the host tissues requires contributions from humoral and Th1 immune responses <xref ref-type="bibr" rid="ppat.1004410-Kamada1">[4]</xref>–<xref ref-type="bibr" rid="ppat.1004410-Bry1">[6]</xref>. However, innate immunity is also important for early bacterial control <xref ref-type="bibr" rid="ppat.1004410-Gibson1">[7]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Gibson2">[8]</xref> and for the initiation of adaptive immunity <xref ref-type="bibr" rid="ppat.1004410-Kim1">[9]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Geddes1">[10]</xref>.</p>
<p>Innate immunity to pathogens depends on a limited set of germ-line encoded pattern recognition receptors (PRRs) that sense conserved pathogen motifs. Innate receptors initiate inflammation through activation of pro-inflammatory transcription factors such as NF-κB, by promoting activation of proinflammatory caspases in inflammasomes, and by initiating programmed cell death of infected cells. The intracellular NOD-like receptors (NLRs) NOD1 and NOD2 recognize peptidoglycan fragments from bacterial cell walls in the cytosol, which results in pro-inflammatory NF-κB and MAP-kinase pathway activation via the adaptor RIP2 <xref ref-type="bibr" rid="ppat.1004410-Girardin1">[11]</xref>–<xref ref-type="bibr" rid="ppat.1004410-Park1">[13]</xref>. However, pathogen infection is frequently accompanied by ion fluxes and vacuolar membrane damage elicited by the action of microbial toxins and effectors of specialized bacterial secretion systems <xref ref-type="bibr" rid="ppat.1004410-MunozPlanillo1">[14]</xref>–<xref ref-type="bibr" rid="ppat.1004410-Casson1">[17]</xref>. Thus, while conserved bacterial peptidoglycan fragments are initially recognized by receptors NOD1 and NOD2, the perturbations inflicted over the course of infection can activate NLRP3.</p>
<p>NLRP3 is the most studied inflammasome-associated NLR. Signaling events initiated by Toll-like receptors (TLRs) contribute to NF-κB mediated up-regulation of NLRP3 and pro-IL-1β for robust activation <xref ref-type="bibr" rid="ppat.1004410-Bauernfeind1">[18]</xref>. No specific pathogen-derived ligand is known to bind and activate NLRP3. Instead, NLRP3 is activated in response to diverse stimuli including microbial, environmental and metabolic perturbations, which culminate in the generation of reactive oxygen species, changes in ion flux or leakage of cathepsin B into the cytoplasm <xref ref-type="bibr" rid="ppat.1004410-Lamkanfi1">[19]</xref>–<xref ref-type="bibr" rid="ppat.1004410-Kanneganti1">[21]</xref>. These cellular damage signals induce NLRP3 to form an inflammasome complex with the adaptor ASC and the cysteine protease caspase-1 that enables the maturation of IL-1β and IL-18 cytokines and pyroptotic cell death <xref ref-type="bibr" rid="ppat.1004410-Kanneganti2">[22]</xref>–<xref ref-type="bibr" rid="ppat.1004410-Miao1">[25]</xref>. An alternative non-canonical pathway of NLRP3 activation that additionally involves upstream caspase-11 activation has been described in response to cytosolic LPS and gram-negative enteric pathogens such as <italic>Citrobacter rodentium</italic> and <italic>Escherichia coli</italic> <xref ref-type="bibr" rid="ppat.1004410-Kayagaki1">[26]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Wang1">[27]</xref>. Recent studies have extended the requirement of the non-canonical inflammasome to other gram-negative pathogens such as flagellin-deficient <italic>Legionella pneumophila (ΔflaA)</italic> <xref ref-type="bibr" rid="ppat.1004410-Case1">[28]</xref> and <italic>Salmonella typhimurium (Δfljb/flic)</italic> <xref ref-type="bibr" rid="ppat.1004410-Broz1">[29]</xref>. Studies from our lab and others suggest that activation of the non-canonical NLRP3 inflammasome requires TLR4-TRIF mediated type-I interferon dependent production of caspase-11 <xref ref-type="bibr" rid="ppat.1004410-Gurung1">[30]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Rathinam1">[31]</xref>. However, whether NLR signaling pathways can regulate the non-canonical NLRP3 inflammasome is not known. Here, we show that activation of the cytoplasmic NOD2-RIP2 pathway modulates caspases-11 expression and activation of the non-canonical inflammasome in response to <italic>C. rodentium</italic> and <italic>Δfljb/flic Salmonella typhimurium</italic> infection.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title><italic>Nod2</italic>- and <italic>Rip2</italic>-deficient cells display enhanced inflammasome activation</title>
<p>Signaling events initiated by TLRs contribute to NF-κB mediated up-regulation of NLRP3 and pro-IL-1β <xref ref-type="bibr" rid="ppat.1004410-Bauernfeind1">[18]</xref>. However, whether TLR or NLR pathways can restrain or negatively regulate inflammasome activation is not known. To examine the role of NOD2 in inflammasome activation, WT and <italic>Nod2<sup>−/−</sup></italic> bone marrow derived macrophages (BMDM) were infected with <italic>C. rodentium</italic> and caspase-1 activation was analyzed at 18 h post-infection. <italic>Nod2</italic>-deficient cells exhibited increased caspase-1 activation and this was accompanied with elevated production of IL-18 (<xref ref-type="fig" rid="ppat-1004410-g001"><bold>Figure 1A–C</bold></xref>). Similarly, <italic>Rip2<sup>−/−</sup></italic> cells displayed increased caspase-1 activation and IL-18 secretion (<xref ref-type="fig" rid="ppat-1004410-g001"><bold>Figure 1D–F</bold></xref>). Furthermore, increased caspase-1 activation was not due to increased bacterial loads because <italic>Nod2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic> macrophages exhibited comparable <italic>C. rodentium</italic> uptake and clearance (<xref ref-type="fig" rid="ppat-1004410-g001"><bold>Fig. 1G</bold></xref>). These results suggest that the NOD2-RIP2 axis negatively regulates inflammasome activation to <italic>C. rodentium</italic> infection.</p>
<fig id="ppat-1004410-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004410.g001</object-id><label>Figure 1</label><caption>
<title>Enhanced inflammasome activation in <italic>Nod2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic> BMDMs.</title>
<p>BMDM were generated from WT, <italic>Nod2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic> mice and infected with 20MOI of <italic>Citrobacter rodentium</italic> for 18 h. <bold>(A–F)</bold> Combined supernatant and lysates were examined by Western blot for caspase-1 cleavage (casp-1p20) visually (A,D) and by densitometry (B,E), or (C,F) supernatants were examined for IL-18 secretion by ELISA. <bold>(G)</bold> BMDM were infected with <italic>C. rodentium</italic> and assayed for intracellular growth at the indicated times post-infection. (A–F) Data are representative of five independent experiments with n = 2–3 wells per experiment. (G) Data are representative of two independent experiments with n = 2–3 wells per experiment. (B,C,E,F,G) Data are shown as the mean ± SEM. (*, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004410.g001" position="float" xlink:type="simple"/></fig></sec><sec id="s2b">
<title>The NOD2-RIP2 axis specifically restricts the NLRP3 inflammasome</title>
<p>Activation of caspase-1 is triggered downstream of several NLRs including NLRP3, NLRP1 and NLRC4 <xref ref-type="bibr" rid="ppat.1004410-Manji1">[23]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Mariathasan1">[32]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Martinon1">[33]</xref>. Previously, we have shown that infection with <italic>C. rodentium</italic> specifically activates the non-canonical NLRP3 inflammasome <xref ref-type="bibr" rid="ppat.1004410-Gurung1">[30]</xref>. To determine the extent of NOD2-RIP2 modulation, we examined whether this pathway also modulates the NLRC4 inflammasome. To answer this, we infected WT, <italic>Nod2</italic>- and <italic>Rip2</italic>-deficient cells with <italic>Salmonella typhimurium</italic> to activate the NLRC4-inflammasome. However, comparable caspase-1 activation was observed in <italic>S. typhimurium</italic> infected WT, <italic>Nod2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic> cells (<xref ref-type="fig" rid="ppat-1004410-g002"><bold>Figure 2A,B</bold></xref>). In agreement, IL-18 levels were similar (<xref ref-type="fig" rid="ppat-1004410-g002"><bold>Figure 2C</bold></xref>) suggesting that the NOD2-RIP2 pathway specifically restricts the NLRP3 inflammasome. The NLRC4 inflammasome is activated upon recognition of <italic>S. typhimurium</italic> flagellin <xref ref-type="bibr" rid="ppat.1004410-Franchi1">[34]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Miao2">[35]</xref>. However, flagellin-deficient <italic>S. typhimurium Δfljb/flic</italic> activates the NLRP3 inflammasome <xref ref-type="bibr" rid="ppat.1004410-Broz1">[29]</xref>. Consequently, <italic>Nod2<sup>−/−</sup></italic> or <italic>Rip2<sup>−/−</sup></italic> BMDM infected with the <italic>S. typhimurium Δfljb/flic</italic> strain displayed enhanced caspase-1 activation and IL-18 production over wildtype BMDM (<xref ref-type="fig" rid="ppat-1004410-g002"><bold>Figure 2D–F</bold></xref>). These results suggest that NOD2 and RIP2 specifically modulated the NLRP3 inflammasome in this model while the NLRC4 inflammasome was not affected by the absence of the NOD2-RIP2 signaling axis.</p>
<fig id="ppat-1004410-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004410.g002</object-id><label>Figure 2</label><caption>
<title>NOD2 and RIP2 specifically regulate NLRP3 inflammasome activation.</title>
<p><bold>(A–B)</bold> WT, <italic>Nod2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 1MOI <italic>Salmonella typhimurium</italic> for 4 h and combined supernatant and lysates were examined by Western blot for caspase-1 cleavage (casp-1p20) visually (A) and by densitometry (B). <bold>(C)</bold> Supernatants were examined 4 h after <italic>S. typhimurium</italic> infection for IL-18 secretion. <bold>(D–F)</bold> WT, <italic>Nod2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 10MOI <italic>S typhimurium Δfljb/flic</italic> mutant for 18 h. Caspase-1 activation and IL-18 were examined as in panels A–C. <bold>(G–I)</bold> WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> for 2 h and <italic>Rip2<sup>−/−</sup></italic> cells were subsequently treated with the NLRP3 specific inhibitor glyburide or mock treated as a control. Caspase-1 activation and IL-18 were examined as in panels A–C. <bold>(J–L)</bold> WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 1MOI of <italic>S. typhimurium</italic> and <italic>Rip2<sup>−/−</sup></italic> cells were simultaneously treated with the NLRP3 specific inhibitor glyburide or mock treated as a control. Caspase-1 activation and IL-18 were examined as in panels A–C. (A–L) Data are representative of three independent experiments with n = 2–3 wells per experiment and displayed as the mean ± SEM. (*, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004410.g002" position="float" xlink:type="simple"/></fig>
<p>Glyburide, a type 2 diabetes drug, has been shown to specifically inhibit the NLRP3 inflammasome in response to microbial and crystalline stimuli <xref ref-type="bibr" rid="ppat.1004410-Lamkanfi2">[36]</xref>. To further verify that the enhanced caspase-1 activation observed in <italic>Nod2</italic>- and <italic>Rip2</italic>-deficient BMDM is the result of elevated NLRP3 inflammasome activation, we exposed <italic>Rip2</italic>-deficient BMDM to glyburide following <italic>C. rodentium</italic> infection. Consistent with the requirement for NLRP3, we observed increased caspase-1 activation in <italic>Rip2</italic>-deficient cells and this was markedly abrogated in the presence of glyburide (<xref ref-type="fig" rid="ppat-1004410-g002"><bold>Figure 2G,H</bold></xref>). In agreement, enhanced IL-18 levels in <italic>Rip2<sup>−/−</sup></italic> BMDM were significantly decreased upon treatment with glyburide (<xref ref-type="fig" rid="ppat-1004410-g002"><bold>Figure 2I</bold></xref>). In contrast, glyburide treatment did not affect caspase-1 activation in <italic>Rip2</italic>-deficient cells infected with <italic>S. typhimurium</italic> (<xref ref-type="fig" rid="ppat-1004410-g002"><bold>Figure 2J,K</bold></xref>). Consequently, IL-18 levels were also unaffected (<xref ref-type="fig" rid="ppat-1004410-g002"><bold>Figure 2L</bold></xref>). These data indicate that NOD2-RIP2 signaling specifically modulates NLRP3 activation and does not regulate all inflammasomes.</p>
</sec><sec id="s2c">
<title><italic>Rip2</italic>-deficient cells show increased ROS production</title>
<p>To determine the cause of increased NLRP3 inflammasome activation during <italic>C. rodentium</italic> infection, we examined the possibility that there is a global dysregulation of cytokines and inflammation in <italic>Rip2</italic>-deficient BMDM. However, there was no difference in IL-6 production and TNF-α levels were lower in <italic>Rip2</italic>-deficient cells (<xref ref-type="fig" rid="ppat-1004410-g003"><bold>Figure 3A</bold></xref>) suggesting that a global increase in inflammation is not responsible for increased NLRP3 inflammasome activation in this model.</p>
<fig id="ppat-1004410-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004410.g003</object-id><label>Figure 3</label><caption>
<title>Increased mitochondrial damage in <italic>Rip2<sup>−/−</sup></italic> cells drives enhanced inflammasome activation.</title>
<p>WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> for 18 h. <bold>(A)</bold> Supernatants were collected and analyzed for IL-6 and TNF-α secretion. <bold>(B–D)</bold> WT-LC3-GFP and <italic>Rip2<sup>−/−</sup></italic>-LC3-GFP BMDM were infected with 20MOI of <italic>C. rodentium</italic> and were examined for LC3<sup>+</sup> autophagosomes (Arrows) at 18 h by confocal microscopy (B–C) or LC3 geometric mean fluorescence intensity (MFI) at 4 h and 18 h by flow cytometry (D). <bold>(E–F)</bold> BMDM were stained with the mitochondrial specific superoxide sensitive dye MitoSOX and analyzed by flow cytometry. <bold>(G–H)</bold> WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> for 2 h and <italic>Rip2<sup>−/−</sup></italic> cells were subsequently treated with NAC or mock treated as a control. After 18 h, supernatant and lysates were combined and examined by Western blot for caspase-1 cleavage (casp-1p20) visually (G) and by densitometry (H). <bold>(I)</bold> Supernatants were also examined at 18 h after <italic>C. rodentium</italic> infection for IL-18 secretion. (A,E–I) Data are representative of three independent experiments with n = 2–4 wells per experiment. (B–C) Data are representative of 2–3 independent experiments with n = 1–3 wells per experiment and displayed as the mean ± SEM. (*, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004410.g003" position="float" xlink:type="simple"/></fig>
<p>Elevated production of reactive oxygen species (ROS) has previously been associated with increased NLRP3 inflammasome activation <xref ref-type="bibr" rid="ppat.1004410-Nakahira1">[37]</xref>. In particular, mitochondrial-derived ROS production was suggested to provoke NLRP3 activation <xref ref-type="bibr" rid="ppat.1004410-Zhou1">[38]</xref>, and we previously demonstrated that <italic>Rip2</italic>-deficient cells have defects in autophagy that lead to the accumulation of damaged mitochondria <xref ref-type="bibr" rid="ppat.1004410-Lupfer1">[39]</xref>. LC3 is an autophagy-associated protein that is localized in the cytosol under steady state conditions, but relocalizes to autophagosome membranes when autophagy occurs <xref ref-type="bibr" rid="ppat.1004410-Kabeya1">[40]</xref>. During <italic>C. rodentium</italic> infection of WT or <italic>Rip2<sup>−/−</sup></italic> BMDM, the number of autophagosomes was examined using confocal microscopy by counting GFP-LC3<sup>+</sup> puncta per cell (<xref ref-type="fig" rid="ppat-1004410-g003"><bold>Figure 3B–C</bold></xref>). Alternatively, we used flow cytometry to measure the fluorescence intensity of GFP-LC3 after permeablizing cells so that only autophagosome membrane bound GFP-LC3 remained (<xref ref-type="fig" rid="ppat-1004410-g003"><bold>Figure 3D</bold></xref>). In both cases, we found that autophagy was impaired in <italic>Rip2<sup>−/−</sup></italic> BMDM compared to WT cells after <italic>C. rodentium</italic> infection. Furthermore, <italic>Rip2</italic>-deficient BMDM exhibited elevated levels of mitochondria-derived superoxide when infected with <italic>C. rodentium</italic> and stained with the mitochondrial specific ROS sensor MitoSOX (<xref ref-type="fig" rid="ppat-1004410-g003"><bold>Figure 3E,F</bold></xref>). Finally, <italic>Rip2<sup>−/−</sup></italic> BMDM treated with the ROS scavenger N-acetyl-L-cysteine (NAC) had reduced caspase-1 activation and IL-18 production compared to WT cells (<xref ref-type="fig" rid="ppat-1004410-g003"><bold>Figure 3G–I</bold></xref>). Thus, the presence of dysfunctional mitochondria in <italic>Rip2<sup>−/−</sup></italic> cells leads to enhanced ROS production and thereby increased NLRP3 inflammasome activation.</p>
</sec><sec id="s2d">
<title>Caspase-11 activation is upregulated in <italic>Rip2</italic>-deficient cells</title>
<p>Enteric pathogens such as <italic>C. rodentium</italic> are known to activate the NLRP3 inflammasome by a non-canonical pathway, which additionally requires caspase-11 for its activation <xref ref-type="bibr" rid="ppat.1004410-Kayagaki1">[26]</xref>. We therefore postulated that during <italic>C. rodentium</italic> infection increased ROS production might act upstream of caspase-11 as well as caspase-1. Therefore, we sought to examine the role of caspase-11 in the present study. First, we determined that activation of caspase-11 is enhanced in <italic>Rip2<sup>−/−</sup></italic> BMDM (<xref ref-type="fig" rid="ppat-1004410-g004"><bold>Fig. 4A,B</bold></xref>). Next, we treated <italic>Rip2<sup>−/−</sup></italic> BMDM with the ROS scavenger NAC following <italic>C. rodentium</italic> infection and observed that caspase-11 activation was significantly diminished compared to mock-treated <italic>Rip2<sup>−/−</sup></italic> BMDM controls (<xref ref-type="fig" rid="ppat-1004410-g004"><bold>Figure 4C,D</bold></xref>). We also found that caspase-11 activation (p30 band) correlated with the expression of p43/p38 (pro-caspase-11). Indeed, densitometric analysis showed that <italic>C. rodentium</italic> infected <italic>Rip2<sup>−/−</sup></italic> BMDM had higher expression of pro-caspase-11 and that treatment with NAC inhibited pro-caspase-11 expression (<xref ref-type="fig" rid="ppat-1004410-g004"><bold>Figure 4E</bold></xref>). Mechanistically, we examined whether the increased caspase-11 seen in <italic>Rip2<sup>−/−</sup></italic> BMDM was the result of defects in protein turnover; however, treatment of WT and <italic>Rip2<sup>−/−</sup></italic> BMDM 4 h after infection with the proteasome inhibitor MG-132 resulted in accumulation of caspase-11 in both WT and <italic>Rip2<sup>−/−</sup></italic> BMDM (<xref ref-type="fig" rid="ppat-1004410-g004"><bold>Figure 4F–G</bold></xref>). Instead, <italic>Casp11</italic> mRNA was higher in <italic>Rip2<sup>−/−</sup></italic> BMDM compared to WT BMDM (<xref ref-type="fig" rid="ppat-1004410-g004"><bold>Figure 4H</bold></xref>). These results indicate that RIP2 regulates caspase-11 at the level of mRNA expression, possibly through enhanced ROS production.</p>
<fig id="ppat-1004410-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004410.g004</object-id><label>Figure 4</label><caption>
<title>RIP2 regulates the caspase-11 non-canonical inflammasome.</title>
<p><bold>(A–B)</bold> WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> for 18 h and combined supernatant and lysates were examined by Western blot for caspase-11 cleavage (casp-11p30) visually (A) and by densitometry (B). <bold>(C–D)</bold> WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> for 2 h and <italic>Rip2<sup>−/−</sup></italic> cells were subsequently treated with NAC or mock treated as a control. Samples were collected at 18 h and caspase-11 activation was examined as in panels A–B. <bold>(E)</bold> Densitometry was performed on pro-Caspase-11 p43 band from 3 independent experiments. <bold>(F–G)</bold> WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> for 4 h and cells were subsequently treated with 1 µM MG-132 or mock treated as a control. Samples were collected at the indicated time points and pro-caspase-11 levels examined by Western blot and densitometry. <bold>(H)</bold> WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> and RNA collected at the indicated time points and analyzed by qRT-PCR for fold induction and normalized to GAPDH. (A–H) Data are representative of three independent experiments with n = 2–3 wells per experiment and displayed as the mean ± SEM. (**, p&lt;0.01; ***, p&lt;0.001).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004410.g004" position="float" xlink:type="simple"/></fig></sec><sec id="s2e">
<title>Exogenous ROS enhances caspase-11 expression and activation in WT cells</title>
<p>To further confirm the role of enhanced ROS production leading to increased inflammasome activation in <italic>Rip2<sup>−/−</sup></italic> BMDM, we examined the effects of treating WT BMDM with exogenous ROS. WT BMDM were infected with <italic>C. rodentium</italic> and treated with H<sub>2</sub>O<sub>2</sub> as a ROS source 6 h after infection. Although H<sub>2</sub>O<sub>2</sub> treatment had no effect on <italic>Il18</italic> mRNA levels following <italic>C. rodentium</italic> infection, we detected significantly more IL-18 in the culture medium (<xref ref-type="fig" rid="ppat-1004410-g005"><bold>Figure 5A,B</bold></xref>). In agreement, caspase-1 activation was also increased following H<sub>2</sub>O<sub>2</sub> treatment (<xref ref-type="fig" rid="ppat-1004410-g005"><bold>Figure 5C</bold></xref>). Importantly, H<sub>2</sub>O<sub>2</sub> treatment of WT cells resulted in increased mRNA and protein expression of caspase-11 by qRT-PCR and Western blot respectively (<xref ref-type="fig" rid="ppat-1004410-g005"><bold>Figure 5D–F</bold></xref>). Our results indicate that ROS produced during <italic>C. rodentium</italic> infection can enhance caspase-11 expression and subsequently potentiate activation of the non-canonical inflammasome.</p>
<fig id="ppat-1004410-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004410.g005</object-id><label>Figure 5</label><caption>
<title>ROS enhances caspase-11 expression.</title>
<p>WT BMDM were infected with 20MOI of <italic>C. rodentium</italic> for 6 h and mock treated or treated with 50 µM of H<sub>2</sub>O<sub>2</sub> as a ROS source. <bold>(A)</bold> BMDM were collected at 8 h or 18 h after initial infection and examined for <italic>Il18</italic> mRNA expression by qRT-PCR. <bold>(B)</bold> Supernatants were collected 18 h post-infection and IL-18 levels determined by ELISA. <bold>(C)</bold> WT BMDMs were examined by Western blot for caspase-1 activation. <bold>(D–F)</bold> Caspase-11 expression was examined at the (D) mRNA level by qRT-PCR or the (E–F) protein level by Western blot and densitometric analysis. (A–F) Data are representative of three independent experiments with n = 2–4 wells per experiment and displayed as the mean ± SD. (*, p&lt;0.05; ***, p&lt;0.001).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004410.g005" position="float" xlink:type="simple"/></fig></sec><sec id="s2f">
<title>ROS regulates caspases-11 through a JNK mediated pathway</title>
<p>Our data indicate that ROS is capable of regulating caspase-11 expression. However, it remains unclear what pathways are regulated by ROS that subsequently affect caspase-11 expression. As a TLR4-TRIF-IFN-β pathway has been established for expression of caspase-11 <xref ref-type="bibr" rid="ppat.1004410-Gurung1">[30]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Rathinam1">[31]</xref>, we examined the level of type-I interferons, but found they were similar between WT, <italic>Rip2<sup>−/−</sup></italic>, and <italic>Nod2<sup>−/−</sup></italic> BMDM (<xref ref-type="fig" rid="ppat-1004410-g006"><bold>Figure 6A</bold></xref>). One pathway that is responsive to ROS is the c-Jun N-terminal kinase (JNK) pathway <xref ref-type="bibr" rid="ppat.1004410-Lo1">[41]</xref>. We next infected WT BMDM with <italic>C. rodentium</italic>, treated them with H<sub>2</sub>O<sub>2</sub> and examined the effects on JNK1/2 phosphorylation. H<sub>2</sub>O<sub>2</sub> treatment resulted in increased JNK phosphorylation compared to mock treated cells (<xref ref-type="fig" rid="ppat-1004410-g006"><bold>Figure 6B</bold></xref>). Similarly, <italic>Rip2<sup>−/−</sup></italic> BMDM infected with <italic>C. rodentium</italic> alone had substantially more JNK1/2 phosphorylation than WT cells (<xref ref-type="fig" rid="ppat-1004410-g006"><bold>Figure 6C</bold></xref>). Finally, we infected WT or <italic>Rip2<sup>−/−</sup></italic> BMDM with <italic>C. rodentium</italic> and then treated <italic>Rip2<sup>−/−</sup></italic> BMDM with the JNK inhibitor SP600125. We observed that caspase-11 levels were reduced in conjunction with reduced JNK1/2 activation (<xref ref-type="fig" rid="ppat-1004410-g006"><bold>Figure 6D</bold></xref>). From these results we propose that in the absence of NOD2-RIP2 signaling, defective autophagy results in the accumulation of ROS and the subsequent enhancement of JNK signaling. This ultimately leads to an increase in caspase-11 expression and non-canonical inflammasome activation (<xref ref-type="fig" rid="ppat-1004410-g006"><bold>Figure 6E</bold></xref>).</p>
<fig id="ppat-1004410-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004410.g006</object-id><label>Figure 6</label><caption>
<title>RIP2 regulates caspases-11 expression through a ROS-JNK pathway.</title>
<p><bold>(A)</bold> WT and <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> for 18 h and supernatants collected and examined for type-I interferon using a reporter cell line (U = Units). <bold>(B–C)</bold> WT or <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> and mock treated or treated with H<sub>2</sub>O<sub>2</sub>. Samples were collected at the indicated times and examined for total JNK or phosphorylated JNK by Western blot. <bold>(D)</bold> WT or <italic>Rip2<sup>−/−</sup></italic> BMDM were infected with 20MOI of <italic>C. rodentium</italic> and mock treated or treated with the JNK inhibitor SP600125 (JNKi). Samples were collected at the indicated times and examined for total JNK, phosphorylated JNK and caspase-11 by western blot. <bold>(E)</bold> Proposed signaling pathway that regulates inflammasome activation. (A) Data are combined from 9 independent experiments and displayed as the mean ± SEM. (B–D) Data are representative of 3 independent experiments. (n.s. = not significant).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004410.g006" position="float" xlink:type="simple"/></fig></sec><sec id="s2g">
<title>Increased non-canonical inflammasome activation provides protection against <italic>C. rodentium</italic> induced colitis</title>
<p>To determine the physiological relevance of our proposed pathway, we examined <italic>Rip2</italic>-deficient mice for IL-18 production and inflammasome activation in the colon during <italic>C. rodentium</italic> induced colitis. On day 10 post-infection, caspase-11 and caspase-1 activation were much higher in colon lysates of <italic>Rip2<sup>−/−</sup></italic> mice compared to WT controls (<xref ref-type="fig" rid="ppat-1004410-g007"><bold>Figure 7A,B</bold></xref>). IL-18 activation was significantly increased by Western blot and IL-18 levels were higher in colon lysates taken from <italic>Rip2<sup>−/−</sup></italic> mice compared to WT controls (<xref ref-type="fig" rid="ppat-1004410-g007"><bold>Figure 7C,D</bold></xref>). In contrast, bacterial loads in the colon were reduced in <italic>Rip2<sup>−/−</sup></italic> versus WT mice (<xref ref-type="fig" rid="ppat-1004410-g007"><bold>Figure 7E</bold></xref>). In agreement, colon tissue examined on day 10 after infection showed increased numbers of bacteria adherent to the mucosal surface in WT compared to <italic>Rip2<sup>−/−</sup></italic> mice (<xref ref-type="fig" rid="ppat-1004410-g007"><bold>Figure 7F</bold></xref>). Intriguingly, colon sections from WT mice also showed more hyperplasia and inflammation and the extent of colon area that was inflamed was more pronounced with WT mice compared to <italic>Rip2<sup>−/−</sup></italic> mice (<xref ref-type="fig" rid="ppat-1004410-g007"><bold>Figure 7F,G</bold></xref>). The stool of <italic>Rip2<sup>−/−</sup></italic> mice also had fewer <italic>C. rodentium</italic> CFU at both day 7 and day 10, highlighting the protective effect of increased inflammasome activation during the innate immune phase of infection (<xref ref-type="fig" rid="ppat-1004410-g007"><bold>Figure 7H</bold></xref>). These results demonstrate that the NOD2-RIP2 pathway plays an important role in regulating the non-canonical NLRP3 inflammasome <italic>in vivo</italic> during <italic>C. rodentium</italic>-induced colitis. Of note, previous reports have demonstrated an essential role for adaptive immunity in the eventual clearance of <italic>C. rodentium</italic> <xref ref-type="bibr" rid="ppat.1004410-Kim1">[9]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Yang1">[42]</xref>. In agreement with these studies, on day 14 after infection, mice deficient in RIP2 signaling had a clearance defect in the stool (<xref ref-type="fig" rid="ppat-1004410-g007"><bold>Figure 7H</bold></xref>). Finally, to verify that increased inflammasome activation and IL-18 production were responsible for the lower bacterial numbers on day 7 or 10, we infected WT, <italic>Rip2<sup>−/−</sup></italic>, and <italic>Rip2<sup>−/−</sup></italic>×<italic>Il18<sup>−/−</sup></italic> mice with <italic>C. rodentium</italic> and examined bacterial loads on day 7 after infection. As before, <italic>Rip2<sup>−/−</sup></italic> mice had significantly lower bacterial numbers compared to WT mice. However, the deletion of IL-18 in <italic>Rip2<sup>−/−</sup></italic>×<italic>Il18<sup>−/−</sup></italic> mice resulted in significantly increased bacterial burden compared to the <italic>Rip2<sup>−/−</sup></italic> mice (<xref ref-type="fig" rid="ppat-1004410-g007"><bold>Figure 7I</bold></xref>).</p>
<fig id="ppat-1004410-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004410.g007</object-id><label>Figure 7</label><caption>
<title>Enhanced inflammasome activation results in protection <italic>in vivo</italic>.</title>
<p>WT and <italic>Rip2<sup>−/−</sup></italic> mice were infected with <italic>C. rodentium</italic>. On day 10 after infection, colon tissue lysates were prepared and analyzed by Western blot for <bold>(A)</bold> caspase-11, <bold>(B)</bold> caspase-1 and <bold>(C)</bold> IL-18. <bold>(D)</bold> IL-18 in colon lysates was also examined by ELISA. <bold>(E)</bold> Colon homogenates were examined for <italic>C. rodentium</italic> colony forming units (CFU) on day 10 after infection. <bold>(F–G)</bold> Colon tissue from WT and <italic>Rip2<sup>−/−</sup></italic> mice was fixed and H&amp;E stained. (F) Arrows indicate adherent bacteria on the epithelial surface. (G) A veterinary pathologist analyzed H&amp;E stained sections for the indicated clinical scores. <bold>(H–I)</bold> Stool samples from <italic>C. rodentium</italic> infected mice were collected on the indicated days (H) or day 7 (I) and analyzed for <italic>C. rodentium</italic> CFU. (A–H) Data are representative of two independent experiments with n = 6–9 mice per genotype per experiment and displayed as the mean ± SEM. (I) Data are combined from 2 experiments and displayed as the mean ± SEM. (*, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004410.g007" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s3">
<title>Discussion</title>
<p>Regulation of the non-canonical NLRP3 inflammasome is still not well understood. It is clear that pathogen entry into the cytosol is required for caspase-11 activation <xref ref-type="bibr" rid="ppat.1004410-Casson1">[17]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Meunier1">[43]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Aachoui1">[44]</xref>. In addition, caspase-11 activation requires guanylate binding protein (GBP) for activation in response to cytosolic LPS <xref ref-type="bibr" rid="ppat.1004410-Pilla1">[45]</xref>. However, the exact upstream LPS sensor has yet to be identified <xref ref-type="bibr" rid="ppat.1004410-Kayagaki2">[46]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Hagar1">[47]</xref>. Although the exact activation mechanism involved is not clear, our lab and others demonstrated that expression of caspase-11 via a TLR4-TRIF-IFN-β-dependent mechanism is necessary for non-canonical NLRP3 inflammasome activation during <italic>C. rodentium</italic> infection <xref ref-type="bibr" rid="ppat.1004410-Gurung1">[30]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Rathinam1">[31]</xref>. Our current findings show that ROS produced during <italic>C. rodentium</italic> infection, or added exogenously to infected cells as H<sub>2</sub>O<sub>2</sub>, is capable of regulating caspase-11 expression. In agreement, treatment with the ROS scavenger NAC dampened caspase-11 expression and activation, and subsequently reduced caspase-1 activation through the non-canonical NLRP3 inflammasome. Mechanistically, <italic>Rip2<sup>−/−</sup></italic> cells display enhanced ROS production following <italic>C. rodentium</italic> infection, and our data define a pathway where ROS acts through JNK signaling to increase caspase-11 expression and the subsequent activation of the non-canonical NLRP3 inflammasome.</p>
<p>Similar to <italic>C. rodentium</italic>, we found that infection with flagellin-deficient <italic>S. typhimurium Δfljb/flic</italic> resulted in augmented inflammasome activation in <italic>Nod2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic> BMDM. Since activation of the NLRC4 inflammasome was comparable between WT and <italic>Rip2</italic>-deficient BMDM infected with WT <italic>S. typhimurium</italic>, these data suggest that NOD2-RIP2 mediated regulation of ROS and JNK activation specifically modulates the non-canonical NLRP3 inflammasome and not NLRC4.</p>
<p>In addition to the mechanistic insight provided by our <italic>in vitro</italic> studies, caspase-1 activation has never been examined in <italic>Rip2<sup>−/−</sup></italic> mice in response to <italic>C. rodentium</italic>. Our findings demonstrate the NOD2-RIP2 pathway helps suppress the non-canonical NLRP3 inflammasome <italic>in vivo</italic> during <italic>C. rodentium</italic> induced colitis. In the absence of RIP2, there is increased caspase-11 and caspase-1 activation and higher levels of processed IL-18. These increases are associated with reduced bacterial burden and protection of the colon epithelium during the innate immune phase of infection (d7–d10). Our findings are thus in line with our previous publications, which show that NLRP3 inflammasome activation and IL-18 production are important for the control of bacterial burden and disease during <italic>C. rodentium</italic> infection <xref ref-type="bibr" rid="ppat.1004410-Liu1">[48]</xref>. The importance of IL-18 in the protection seen in this model was also confirmed through the use of <italic>Rip2<sup>−/−</sup></italic>×<italic>Il18<sup>−/−</sup></italic> mice. Although IL-18 deletion in <italic>Rip2<sup>−/−</sup></italic> mice did not entirely abolish the protective phenotype, this is likely due to pyroptosis or other functions of caspase-11, such as lysosome-phagosome fusion <xref ref-type="bibr" rid="ppat.1004410-Akhter1">[49]</xref>.</p>
<p>Other reports have examined NOD2 signaling <italic>in vivo</italic>. However, these reports focused on the effects of NOD2-RIP2 signaling on the adaptive immune response. Intriguingly, similar results to ours were published for the ubiquitin ligase pellino3, which is required for NOD2-RIP2 signaling. At early time points, <italic>Peli3<sup>−/−</sup></italic> mice had reduced bacterial burden similar to our model, but after d14, these mice showed a clearance defect <xref ref-type="bibr" rid="ppat.1004410-Yang1">[42]</xref>. On the other hand, <italic>Nod2<sup>−/−</sup></italic> mice displayed reduced production of the chemokine CCL2, which ultimately lead to impaired adaptive immunity and impaired clearance of <italic>C. rodentium</italic> after d14 of infection <xref ref-type="bibr" rid="ppat.1004410-Kim1">[9]</xref>. Collectively, these findings suggest that increased NLRP3 inflammasome activation provides protection early during the innate immune phase, but the defects in adaptive immunity that are also present in <italic>Nod2<sup>−/−</sup>, Rip2<sup>−/−</sup>, or Peli3<sup>−/−</sup></italic> mice ultimately lead to an inability of these mice to resolve the infection.</p>
<p>Although inflammation and cell death are important for bacterial clearance <xref ref-type="bibr" rid="ppat.1004410-Miao1">[25]</xref>, they also increase the likelihood of bacterial dissemination to other tissues and induction of severe inflammatory responses by increased tissue damage and released cellular contents <xref ref-type="bibr" rid="ppat.1004410-Monack1">[50]</xref>–<xref ref-type="bibr" rid="ppat.1004410-Willingham1">[52]</xref>. Therefore, the sequential and carefully orchestrated activation of inflammatory pathways is essential for pathogen clearance as well as maintaining homeostasis in the host. Initial recognition of specific peptidoglycan fragments from bacterial cell walls by the NOD2-RIP2 pathway, results in pro-inflammatory NF-κB and MAP-kinase activation within minutes of infection <xref ref-type="bibr" rid="ppat.1004410-Anand1">[53]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Bertrand1">[54]</xref>. However, if this initial inflammatory burst is inadequate, then subsequent inflammatory pathways, such as the non-canonical NLRP3 inflammasome, are initiated. One common feature of pathogens that activate the non-canonical NLRP3 inflammasome is activation proceeds with slower kinetics than during canonical activation. In all instances, non-canonical NLRP3 inflammasome activation is observed only after a time-period of 12 to 16 h <xref ref-type="bibr" rid="ppat.1004410-Kayagaki1">[26]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Case1">[28]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Gurung1">[30]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Rathinam1">[31]</xref>, whereas canonical activation requires less than 1 h <xref ref-type="bibr" rid="ppat.1004410-Kanneganti1">[21]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Kanneganti2">[22]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Mariathasan2">[55]</xref>. Based on our results, we propose that NOD2-RIP2 signaling initially suppresses or delays non-canonical NLRP3 inflammasome activation by preventing or removing mitochondrial damage. However, extended assault from <italic>C. rodentium</italic> eventually overcomes these mechanisms and leads to ROS generation and activation of the non-canonical NLRP3 inflammasome <xref ref-type="bibr" rid="ppat.1004410-Tschopp1">[20]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Lupfer1">[39]</xref>, <xref ref-type="bibr" rid="ppat.1004410-SaidSadier1">[56]</xref>. In the absence of NOD2 or RIP2, increased mitochondrial damage and ROS production leads to elevated JNK activation, and in turn to augmented non-canonical NLRP3 inflammasome activation. During <italic>C. rodentium</italic> infection <italic>in vivo</italic>, this impaired initial bacterial colonization of the colon and provided protection of the epithelium up to days 10 after infection. However, in other colitis models, increased inflammasome activation may result in increased damage to the colon tissue if left unchecked. The NOD2-RIP2 pathway has been associated with Crohn's disease in humans <xref ref-type="bibr" rid="ppat.1004410-Hugot1">[57]</xref> and plays an essential role in several mouse models of colitis <xref ref-type="bibr" rid="ppat.1004410-Reingold1">[58]</xref>–<xref ref-type="bibr" rid="ppat.1004410-Amendola1">[62]</xref>. As <italic>Rip2</italic>-deficiency leads to enhanced inflammasome activation, it will be of interest to examine caspase-1 activation in other models where inflammation is a key factor and where the NOD2-RIP2 axis is involved.</p>
</sec><sec id="s4" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Ethics statement</title>
<p>Experiments were conducted under protocols approved by the St. Jude Children's Research Hospital Committee on Use and Care of Animals (Protocol #482) and were performed in accordance with institutional policies, AAALAC guidelines, the AVMA Guidelines on Euthanasia (CO<sub>2</sub> asphyxiation followed by cervical dislocation), NIH regulations (Guide for the Care and Use of Laboratory Animals), and the United States Animal Welfare Act (1966).</p>
</sec><sec id="s4b">
<title>Mice</title>
<p>All mice were maintained at SJCRH and were backcrossed for at least 10 generations onto the C57BL/6J (B6) background. <italic>Nod2<sup>−/−</sup></italic>, <italic>Rip2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic>×<italic>Il18<sup>−/−</sup></italic> mice have been reported previously <xref ref-type="bibr" rid="ppat.1004410-Lupfer1">[39]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Kobayashi1">[63]</xref>, <xref ref-type="bibr" rid="ppat.1004410-Kobayashi2">[64]</xref>. WT-GFP-LC3<sup>+</sup> and <italic>Rip2<sup>−/−</sup></italic>-GFP-LC3<sup>+</sup> mice were generated by crossing WT or <italic>Rip2<sup>−/−</sup></italic> mice with LysM-Cre<sup>+</sup> <italic>Atg7<sup>loxP/loxP</sup></italic> GFP-LC3<sup>+</sup> mice <xref ref-type="bibr" rid="ppat.1004410-Lupfer1">[39]</xref> and selecting progeny that only contained the GFP-LC3 transgene but not LysM-Cre or <italic>Atg7<sup>loxP/loxP</sup></italic>. All mice were housed in the SJCRH animal resource center, which is a specific pathogen free (SPF) and AAALAC accredited facility.</p>
</sec><sec id="s4c">
<title>Bacterial infection, caspase-1 activation and IL-18 production</title>
<p>WT, <italic>Nod2</italic><sup>−/−</sup> and <italic>Rip2</italic><sup>−/−</sup> bone marrow derived macrophages (BMDM) were differentiated in complete IMDM containing 10% heat-inactivated FBS and supplemented with M-CSF containing L929 supernatant at 37°C in a humidified atmosphere containing 5% CO2 for 5 days. <italic>Citrobacter rodentium</italic> (ATCC 51459), <italic>Salmonella typhimurium</italic> (SL1344), <italic>Salmonella typhimurium</italic> Δ<italic>fljb/flic</italic> were grown in LB broth overnight with shaking at 37°C. Next day, the bacteria were subcultured to mid-log phase, washed in PBS and BMDM were infected with 20 multiplicity of infection (MOI) of <italic>C. rodentium</italic>, 1MOI <italic>of S. typhimurium</italic>, or 10MOI of <italic>S. typhimurium</italic> Δ<italic>fljb/flic</italic>. Cell lysates combined with supernatants were collected after 18 h of infection and assessed for caspase-1 activation by Western blot using the anti-caspase-1 p20 antibody from Adipogen (AG-20B-0042-C100). Western blots were imaged on a Kodak IMM4000pro and the densitometry performed using the Carestream software provided by the manufacturer. Caspase-1 p20 levels were normalized to the proCaspase-1 for that lane. Supernatants collected at 18 h after infection were analyzed for IL-6, TNF-α, or IL-18 by ELISA according to the manufacturer's instructions (eBiosciences) or for type-I interferon by the RAW-Blue ISG cell line (Invivogen).</p>
</sec><sec id="s4d">
<title><italic>C. rodentium</italic> growth assay in BMDM</title>
<p>WT, <italic>Nod2<sup>−/−</sup></italic> and <italic>Rip2<sup>−/−</sup></italic> macrophages were grown in 24-well plates and infected with 10 MOI of <italic>C. rodentium</italic> at 37°C. After 2 h of infection, cells were washed three times with PBS and 10 µg/ml of gentamicin was added to kill extracellular bacteria. Cells were lysed in 0.1% Triton X-100 at indicated times and lysates were serially diluted and plated on LB agar plates. The colonies were counted after 18 h of growth at 37°C</p>
</sec><sec id="s4e">
<title>Treatments</title>
<p>For SP600125 (JNK inhibitor, 10 µM, Santa Cruz Biotechnology), N-acetyl-L-cysteine (NAC, 10 mM, Sigma) or glyburide (200 µM, Sigma) treatment, BMDMs were exposed to these inhibitors after 2 h of <italic>C. rodentium</italic> infection. For H<sub>2</sub>O<sub>2</sub> treatment, BMDM were treated at 6 h after infection. For MG-132 (1 µM) treatment, BMDM were treated at 4 h after infection, at 2, 4, 8 or 18 h after infection, supernatants were collected for ELISA and cells or cells + supernatants were lysed with RIPA buffer containing protease inhibitors and phosphatase inhibitors (Calbiochem), followed by boiling in sodium dodecyl sulfate (SDS) sample buffer and examined by Western blot. Anti-caspase-1 p20 (Adipogen), anti-caspase-1 p10 (Santa Cruz Biotechnology, A20), anti-total JNK (Cell signaling Technologies, 9252), anti-phospho JNK (Cell signaling Technologies, 9251L) and anti-caspase-11 antibodies (Enzo, 4E11) were used for Western blot detection and equal loading was verified by blotting with anti-GAPDH or anti-Tubulin (Cell Signaling Technologies). HRP-labeled anti-mouse or -rabbit antibodies were obtained from Jackson Immuno Research. Caspase-11 densitometry was normalized to the procaspase-11 level in the uninfected lane for each sample. Phospho-JNK densitometry was normalized to GAPDH loading control for each lane. IL-18 levels were determined in the supernatants by ELISA according to manufacturer's instructions (eBioscience). Alternatively, cells were collected at the indicated time points and RNA isolated for analysis by qRT-PCR. Primers: GAPDH forward <named-content content-type="gene" xlink:type="simple">5′-CGTCCCGTAGACAAAATGGT-3′</named-content> reverse <named-content content-type="gene" xlink:type="simple">5′-TTGATGGCAACAATCTCCAC-3′</named-content>; IL-18 forward <named-content content-type="gene" xlink:type="simple">5′-GCCTCAAACCTTCCAAATCA-3′</named-content> reverse <named-content content-type="gene" xlink:type="simple">5′-TGGATCCATTTCCTCAAAGG-3′</named-content>; Caspase-11 forward <named-content content-type="gene" xlink:type="simple">5′-ACAATGCTGAACGCAGTGAC-3′</named-content> reverse <named-content content-type="gene" xlink:type="simple">5′-CTGGTTCCTCCATTTCCAGA-3′</named-content>.</p>
</sec><sec id="s4f">
<title>ROS production</title>
<p>For staining mitochondria, uninfected BMDMs were used as controls or infected with 20MOI of <italic>C. rodentium</italic> for 18 h and then stained for 30 min in fresh medium containing 5 µM MitoSOX. Cells were then washed in HBSS, resuspended in flow cytometry buffer (DPBS with 1% FBS and 0.04% NaN3) and analyzed immediately by flow cytometry.</p>
</sec><sec id="s4g">
<title>Autophagy</title>
<p>WT-GFP-LC3<sup>+</sup> and <italic>Rip2<sup>−/−</sup></italic>-GFP-LC3<sup>+</sup> mice were used to generate BMDM as before and cells were infected with 20MOI of <italic>C. rodentium</italic> for 4 h or 18 h. Cells were then permeabilized with 0.05% saponin in PBS for 5 min to remove cytosolic GFP-LC3 and cells were fixed in 4% paraformaldehyde in PBS for 5 min. Cells were then examined by fluorescence confocal microscopy for the number of GFP-LC3<sup>+</sup> puncta after staining with Alexafluor 647 phalloidin and mounting with ProLong Gold+DAPI (Life Technologies). Alternatively, cell were scraped from wells and resuspended in FACS buffer and examined by flow cytometry for GFP intensity as a readout of autophagy.</p>
</sec><sec id="s4h">
<title><italic>Citrobacter rodentium</italic> induced colitis</title>
<p>Age and sex matched 8–10 week old mice were infected with 10<sup>10</sup> CFU of <italic>C. rodentium</italic> by oral gavage. Stool was collected from mice for CFU at the indicated time points. Mice were euthanized on D10 and colons collected for CFU determination by homogenizing in PBS or for Western blot by homogenizing in RIPA buffer containing protease inhibitors and phosphatase inhibitors (Calbiochem). Protein concentration was normalized and samples analyzed by western blot; anti-IL-18 (MBL, 39-3F) anti-caspase-1 p10 (Santa Cruz Biotechnology, A20) and anti-caspase-11 antibodies (Enzo, 4E11) were used. Lysates were additionally examined by ELISA for IL-18 (Ebiosciences) and normalized to total protein. D10 colon samples were also collected, formalin fixed and processed for routine histopathological examination by hematoxylin and eosin staining. Sections were examined by a board certified veterinary pathologist (Peter Vogel) for inflammation, bacterial invasion of epithelial surface, and distribution of inflammation.</p>
</sec><sec id="s4i">
<title>Statistics</title>
<p>All statistical analyses were performed using GraphPad Prisim 6.0. Students <italic>t</italic>-Test was used for single comparisons and One-Way ANOVA with Dunnett's or Sidak's post-hoc test for multiple comparisons. Two-way ANOVA was used to analyze <italic>C. rodentium</italic> growth between groups over time.</p>
</sec></sec></body>
<back>
<ack>
<p>We thank Prajwal Gurung, John Lukens, and Si Ming Man for helpful review of the manuscript. We also thank Richard Flavell (Yale University) for the generous supply of mutant mice.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ppat.1004410-Kaper1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaper</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Nataro</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Mobley</surname><given-names>HL</given-names></name> (<year>2004</year>) <article-title>Pathogenic Escherichia coli</article-title>. <source>Nat Rev Microbiol</source> <volume>2</volume>: <fpage>123</fpage>–<lpage>140</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Borenshtein1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Borenshtein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>McBee</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Schauer</surname><given-names>DB</given-names></name> (<year>2008</year>) <article-title>Utility of the Citrobacter rodentium infection model in laboratory mice</article-title>. <source>Curr Opin Gastroenterol</source> <volume>24</volume>: <fpage>32</fpage>–<lpage>37</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Mundy1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mundy</surname><given-names>R</given-names></name>, <name name-style="western"><surname>MacDonald</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Dougan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Frankel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wiles</surname><given-names>S</given-names></name> (<year>2005</year>) <article-title>Citrobacter rodentium of mice and man</article-title>. <source>Cell Microbiol</source> <volume>7</volume>: <fpage>1697</fpage>–<lpage>1706</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kamada1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kamada</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Sham</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Vallance</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Puente</surname><given-names>JL</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Regulated virulence controls the ability of a pathogen to compete with the gut microbiota</article-title>. <source>Science</source> <volume>336</volume>: <fpage>1325</fpage>–<lpage>1329</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Simmons1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simmons</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Clare</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ghaem-Maghami</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Uren</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Rankin</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium</article-title>. <source>Infect Immun</source> <volume>71</volume>: <fpage>5077</fpage>–<lpage>5086</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Bry1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bry</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Brenner</surname><given-names>MB</given-names></name> (<year>2004</year>) <article-title>Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen</article-title>. <source>J Immunol</source> <volume>172</volume>: <fpage>433</fpage>–<lpage>441</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Gibson1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibson</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bergstrom</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Man</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis</article-title>. <source>Cell Microbiol</source> <volume>10</volume>: <fpage>618</fpage>–<lpage>631</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Gibson2"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibson</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rosenberger</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Bergstrom</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Valdez</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis</article-title>. <source>Cell Microbiol</source> <volume>10</volume>: <fpage>388</fpage>–<lpage>403</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kim1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Kamada</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Warner</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>GY</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes</article-title>. <source>Immunity</source> <volume>34</volume>: <fpage>769</fpage>–<lpage>780</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Geddes1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Geddes</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Rubino</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Magalhaes</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Streutker</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Le Bourhis</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Identification of an innate T helper type 17 response to intestinal bacterial pathogens</article-title>. <source>Nat Med</source> <volume>17</volume>: <fpage>837</fpage>–<lpage>844</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Girardin1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Girardin</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Tournebize</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mavris</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Page</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri</article-title>. <source>EMBO Rep</source> <volume>2</volume>: <fpage>736</fpage>–<lpage>742</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Bertin1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bertin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nir</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Tayber</surname><given-names>OV</given-names></name>, <name name-style="western"><surname>Errada</surname><given-names>PR</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB</article-title>. <source>J Biol Chem</source> <volume>274</volume>: <fpage>12955</fpage>–<lpage>12958</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Park1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>McDonald</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Hasegawa</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs</article-title>. <source>J Immunol</source> <volume>178</volume>: <fpage>2380</fpage>–<lpage>2386</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-MunozPlanillo1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Munoz-Planillo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kuffa</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Martinez-Colon</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Rajendiran</surname><given-names>TM</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>K(+) Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter</article-title>. <source>Immunity</source> <volume>38</volume>: <fpage>1142</fpage>–<lpage>1153</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Meixenberger1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meixenberger</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pache</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Eitel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schmeck</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hippenstiel</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3</article-title>. <source>J Immunol</source> <volume>184</volume>: <fpage>922</fpage>–<lpage>930</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Witzenrath1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Witzenrath</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pache</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lorenz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Koppe</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Gutbier</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia</article-title>. <source>J Immunol</source> <volume>187</volume>: <fpage>434</fpage>–<lpage>440</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Casson1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Casson</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Copenhaver</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Zwack</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>HT</given-names></name>, <name name-style="western"><surname>Strowig</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Caspase-11 activation in response to bacterial secretion systems that access the host cytosol</article-title>. <source>PLoS Pathog</source> <volume>9</volume>: <fpage>e1003400</fpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Bauernfeind1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bauernfeind</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Horvath</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stutz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alnemri</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>MacDonald</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression</article-title>. <source>J Immunol</source> <volume>183</volume>: <fpage>787</fpage>–<lpage>791</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Lamkanfi1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name> (<year>2010</year>) <article-title>Nlrp3: an immune sensor of cellular stress and infection</article-title>. <source>Int J Biochem Cell Biol</source> <volume>42</volume>: <fpage>792</fpage>–<lpage>795</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Tschopp1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schroder</surname><given-names>K</given-names></name> (<year>2010</year>) <article-title>NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?</article-title> <source>Nat Rev Immunol</source> <volume>10</volume>: <fpage>210</fpage>–<lpage>215</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kanneganti1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nunez</surname><given-names>G</given-names></name> (<year>2007</year>) <article-title>Intracellular NOD-like receptors in host defense and disease</article-title>. <source>Immunity</source> <volume>27</volume>: <fpage>549</fpage>–<lpage>559</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kanneganti2"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Ozoren</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Body-Malapel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Amer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JH</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3</article-title>. <source>Nature</source> <volume>440</volume>: <fpage>233</fpage>–<lpage>236</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Manji1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Manji</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Geddes</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Merriam</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B</article-title>. <source>J Biol Chem</source> <volume>277</volume>: <fpage>11570</fpage>–<lpage>11575</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Fink1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fink</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Cookson</surname><given-names>BT</given-names></name> (<year>2005</year>) <article-title>Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells</article-title>. <source>Infect Immun</source> <volume>73</volume>: <fpage>1907</fpage>–<lpage>1916</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Miao1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miao</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Leaf</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Treuting</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Dors</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria</article-title>. <source>Nat Immunol</source> <volume>11</volume>: <fpage>1136</fpage>–<lpage>1142</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kayagaki1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Warming</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vande Walle</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Louie</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Non-canonical inflammasome activation targets caspase-11</article-title>. <source>Nature</source> <volume>479</volume>: <fpage>117</fpage>–<lpage>121</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Wang1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE</article-title>. <source>Cell</source> <volume>92</volume>: <fpage>501</fpage>–<lpage>509</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Case1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Case</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Kohler</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Lima</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Strowig</surname><given-names>T</given-names></name>, <name name-style="western"><surname>de Zoete</surname><given-names>MR</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>110</volume>: <fpage>1851</fpage>–<lpage>1856</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Broz1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Broz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ruby</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Belhocine</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bouley</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1</article-title>. <source>Nature</source> <volume>490</volume>: <fpage>288</fpage>–<lpage>291</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Gurung1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gurung</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Malireddi</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Anand</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Demon</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Walle</surname><given-names>LV</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-beta (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens</article-title>. <source>J Biol Chem</source> <volume>287</volume>: <fpage>34474</fpage>–<lpage>34483</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Rathinam1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rathinam</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Vanaja</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Waggoner</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sokolovska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria</article-title>. <source>Cell</source> <volume>150</volume>: <fpage>606</fpage>–<lpage>619</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Mariathasan1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mariathasan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Monack</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Vucic</surname><given-names>D</given-names></name>, <name name-style="western"><surname>French</surname><given-names>DM</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf</article-title>. <source>Nature</source> <volume>430</volume>: <fpage>213</fpage>–<lpage>218</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Martinon1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinon</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Burns</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name> (<year>2002</year>) <article-title>The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta</article-title>. <source>Mol Cell</source> <volume>10</volume>: <fpage>417</fpage>–<lpage>426</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Franchi1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Franchi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Amer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Body-Malapel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Ozoren</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages</article-title>. <source>Nat Immunol</source> <volume>7</volume>: <fpage>576</fpage>–<lpage>582</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Miao2"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miao</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Alpuche-Aranda</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Dors</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Bader</surname><given-names>MW</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf</article-title>. <source>Nat Immunol</source> <volume>7</volume>: <fpage>569</fpage>–<lpage>575</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Lamkanfi2"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mueller</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Vitari</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Misaghi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fedorova</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Glyburide inhibits the Cryopyrin/Nalp3 inflammasome</article-title>. <source>J Cell Biol</source> <volume>187</volume>: <fpage>61</fpage>–<lpage>70</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Nakahira1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakahira</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Haspel</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Rathinam</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Dolinay</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome</article-title>. <source>Nat Immunol</source> <volume>12</volume>: <fpage>222</fpage>–<lpage>230</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Zhou1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yazdi</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Menu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name> (<year>2011</year>) <article-title>A role for mitochondria in NLRP3 inflammasome activation</article-title>. <source>Nature</source> <volume>469</volume>: <fpage>221</fpage>–<lpage>225</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Lupfer1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lupfer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Anand</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Milasta</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection</article-title>. <source>Nat Immunol</source> <volume>14</volume>: <fpage>480</fpage>–<lpage>488</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kabeya1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kabeya</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Mizushima</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ueno</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kirisako</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing</article-title>. <source>EMBO J</source> <volume>19</volume>: <fpage>5720</fpage>–<lpage>5728</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Lo1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lo</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Cruz</surname><given-names>TF</given-names></name> (<year>1996</year>) <article-title>Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases</article-title>. <source>J Biol Chem</source> <volume>271</volume>: <fpage>15703</fpage>–<lpage>15707</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Yang1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Humphries</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Healy</surname><given-names>ME</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis</article-title>. <source>Nat Immunol</source> <volume>14</volume>: <fpage>927</fpage>–<lpage>936</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Meunier1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meunier</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Dick</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Dreier</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Schurmann</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kenzelmann Broz</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases</article-title>. <source>Nature</source> <volume>509</volume>: <fpage>366</fpage>–<lpage>370</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Aachoui1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aachoui</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Leaf</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Hagar</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Fontana</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Campos</surname><given-names>CG</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Caspase-11 protects against bacteria that escape the vacuole</article-title>. <source>Science</source> <volume>339</volume>: <fpage>975</fpage>–<lpage>978</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Pilla1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pilla</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Hagar</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Haldar</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Degrandi</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>111</volume>: <fpage>6046</fpage>–<lpage>6051</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kayagaki2"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Stowe</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Ramani</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>LC</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Noncanonical inflammasome activation by intracellular LPS independent of TLR4</article-title>. <source>Science</source> <volume>341</volume>: <fpage>1246</fpage>–<lpage>1249</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Hagar1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hagar</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Aachoui</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Miao</surname><given-names>EA</given-names></name> (<year>2013</year>) <article-title>Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock</article-title>. <source>Science</source> <volume>341</volume>: <fpage>1250</fpage>–<lpage>1253</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Liu1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zaki</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gurung</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Finlay</surname><given-names>BB</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Role of inflammasomes in host defense against Citrobacter rodentium infection</article-title>. <source>J Biol Chem</source> <volume>287</volume>: <fpage>16955</fpage>–<lpage>16964</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Akhter1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akhter</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Caution</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Abu Khweek</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tazi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Abdulrahman</surname><given-names>BA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization</article-title>. <source>Immunity</source> <volume>37</volume>: <fpage>35</fpage>–<lpage>47</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Monack1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Monack</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Hersh</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ghori</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bouley</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zychlinsky</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model</article-title>. <source>J Exp Med</source> <volume>192</volume>: <fpage>249</fpage>–<lpage>258</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kovarova1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kovarova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hesker</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Jania</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Snouwaert</surname><given-names>JN</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice</article-title>. <source>J Immunol</source> <volume>189</volume>: <fpage>2006</fpage>–<lpage>2016</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Willingham1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Willingham</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Bergstralh</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Brickey</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>MT</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways</article-title>. <source>J Immunol</source> <volume>183</volume>: <fpage>2008</fpage>–<lpage>2015</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Anand1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anand</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Tait</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Amer</surname><given-names>AO</given-names></name>, <name name-style="western"><surname>Nunez</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation</article-title>. <source>J Biol Chem</source> <volume>286</volume>: <fpage>42981</fpage>–<lpage>42991</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Bertrand1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bertrand</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Doiron</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Labbe</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Korneluk</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>PA</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2</article-title>. <source>Immunity</source> <volume>30</volume>: <fpage>789</fpage>–<lpage>801</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Mariathasan2"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mariathasan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>K</given-names></name>, <name name-style="western"><surname>McBride</surname><given-names>J</given-names></name>, <name name-style="western"><surname>O'Rourke</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Cryopyrin activates the inflammasome in response to toxins and ATP</article-title>. <source>Nature</source> <volume>440</volume>: <fpage>228</fpage>–<lpage>232</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-SaidSadier1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Said-Sadier</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Padilla</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Langsley</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ojcius</surname><given-names>DM</given-names></name> (<year>2010</year>) <article-title>Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase</article-title>. <source>PLoS One</source> <volume>5</volume>: <fpage>e10008</fpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Hugot1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hugot</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Chamaillard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zouali</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lesage</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cezard</surname><given-names>JP</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease</article-title>. <source>Nature</source> <volume>411</volume>: <fpage>599</fpage>–<lpage>603</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Reingold1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reingold</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rahal</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Schmiedlin-Ren</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Rittershaus</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Bender</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Development of a peptidoglycan-polysaccharide murine model of Crohn's disease: effect of genetic background</article-title>. <source>Inflamm Bowel Dis</source> <volume>19</volume>: <fpage>1238</fpage>–<lpage>1244</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Jamontt1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jamontt</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Petit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Parkinson</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>P</given-names></name> (<year>2013</year>) <article-title>Nucleotide-binding oligomerization domain 2 signaling promotes hyperresponsive macrophages and colitis in IL-10-deficient mice</article-title>. <source>J Immunol</source> <volume>190</volume>: <fpage>2948</fpage>–<lpage>2958</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-CouturierMaillard1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Couturier-Maillard</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Secher</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rehman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Normand</surname><given-names>S</given-names></name>, <name name-style="western"><surname>De Arcangelis</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer</article-title>. <source>J Clin Invest</source> <volume>123</volume>: <fpage>700</fpage>–<lpage>711</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Watanabe1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watanabe</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kitani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Wakatsuki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fuss</surname><given-names>IJ</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis</article-title>. <source>Immunity</source> <volume>25</volume>: <fpage>473</fpage>–<lpage>485</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Amendola1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amendola</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Butera</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sanchez</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Strober</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Boirivant</surname><given-names>M</given-names></name> (<year>2013</year>) <article-title>Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms</article-title>. <source>Mucosal Immunol</source> <volume>7</volume>: <fpage>391</fpage>–<lpage>404</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kobayashi1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kobayashi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Inohara</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Galan</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Nunez</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems</article-title>. <source>Nature</source> <volume>416</volume>: <fpage>194</fpage>–<lpage>199</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004410-Kobayashi2"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kobayashi</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Chamaillard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ogura</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Henegariu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Inohara</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract</article-title>. <source>Science</source> <volume>307</volume>: <fpage>731</fpage>–<lpage>734</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>